SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-19-009777
Filing Date
2019-05-30
Accepted
2019-05-30 09:50:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0519soder_bioxytran.htm SC 13D 50489
  Complete submission text file 0001213900-19-009777.txt   52093
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Subject) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-84839 | Film No.: 19864903
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 HAMMOND STREET UNIT 2 WALTHAM MA 02451
Business Address
Soderquist Ola (Filed by) CIK: 0001754429 (see all company filings)

Type: SC 13D